Version: Click here to use the Query Builder for Version 21.

Item Search:

CHAPTER VIII:

REQUIRED STATUS TABLE (ITEM # ORDER)

The following table presents Version 21 of the NAACCR required status summarizing the requirements and recommendations for collection of each item by standard-setting groups. Differences from Version 18 are marked “Revised” or “New” in the “Note” column of the table and are highlighted in the body of the table. Text of previous versions is revealed by hovering over a highlighted cell.

 

NPCR Refers to requirements and recommendations of the NPCR regarding data items that should be collected or computed by NPCR state registries. The NPCR transmit column in the Required Status Table has been removed with Version 11.2. Transmit instructions will be provided by NPCR. Note: Patient identifying data items collected are not transmitted to CDC.
CoC Refers to requirements of CoC. CoC-accredited cancer program registries are required to collect the indicated items in the “Collect” column. Facilities should refer to the CoC STORE manual for further clarification of required fields. The CoC Transmit column has been removed with Version 21. Note: Patient identifying data items collected are not transmitted to the NCDB. The Transmit column has been removed with Version 21.
SEER Refers to requirements of NCI’s SEER Program. Central registries are required to collect the indicated items in the “Collect” column. Facilities and central registries should refer to the SEER Program Code Manual for further clarification of required fields. The SEER Transmit column has been removed with Version 21.
CCCR Refers to requirements of CCCR for cases submitted to the Canadian Cancer Registry. Provincial/Territorial registries should refer to the  Canadian Cancer Registry Collection Documentation for further clarification of fields. Items indicated in the “Collect” column are required to be collected at the registry level and reported to the Canadian Cancer Registry. CCCR requirements have been added to the Required Status Table with Version 11.2. The Transmit column has been removed with Version 21.

Codes for Recommendations:

 

 . No recommendation
D Derived
D* Derived, when available
R Required
R# Required; central registries may code available data using either SEER or CoC data items and associated rules
R* Required, when available
R^ Required, these text requirements may be met with one or several text block fields
RC Collected by SEER from CoC-accredited hospitals
RH Historically collected and currently transmitted
RH* Historically collected and currently transmitted when available
RS Required, site specific
RS* Required, site specific; when available
S Supplementary/recommended
Item #Item NameNPCRCoCSEERCCCRSource of StandardNote
CollectCollectCollectCollect
10Record TypeR.R.RRRNAACCR
20Patient ID NumberR..RRR*R*Reporting Registry
21Patient System ID-Hosp.......NAACCR
30Registry Type.......NAACCR
35FIN Coding SystemRetired
37Reserved 00Retired
40Registry IDR..RRRRNAACCR
45NPI--Registry ID...R*...CMS
50NAACCR Record VersionR.RRR..NAACCR
60Tumor Record Number...SSR*R*NAACCR
70Addr at DX--CityRRRR.R*R*CoC
80Addr at DX--StateRRRRR..CoC
81State at DX Geocode 1970/80/90D..RR..NAACCR
82State at DX Geocode 2000D..RR..NAACCR
83State at DX Geocode 2010D..R*R*..NAACCR
84State at DX Geocode 2020D......NAACCR
89County at DX AnalysisD..RR..NAACCR
90County at DX ReportedRRRRR..FIPS/SEER
94County at DX Geocode 1970/80/90D..DR..NAACCR
95County at DX Geocode2000D..DR..NAACCR
96County at DX Geocode2010D..DR..NAACCR
97County at DX Geocode2020D......NAACCR
100Addr at DX--Postal CodeRRRR.R*R*CoC
102Addr at DX--Country.RRR...NAACCR
110Census Tract 1970/80/90RH*..RHRH..SEER
120Census Cod Sys 1970/80/90RH*..RHRH..SEER
125Census Tract 2020D..R*R*..NAACCR
130Census Tract 2000RH..RHRH..NAACCR
135Census Tract 2010R..RR..NAACCR
140Census Tract Cod Sys--AltRetired
145Census Tr Poverty IndictrD..DR..NAACCRRevised
150Marital Status at DX...RR..SEER
160Race 1RRRRR..SEER/CoC
161Race 2R.RRR..SEERRevised
162Race 3R.RRR..SEERRevised
163Race 4R.RRR..SEERRevised
164Race 5R.RRR..SEERRevised
170Race Coding Sys--Current..R....NAACCRRevised
180Race Coding Sys--Original..R....NAACCRRevised
190Spanish/Hispanic OriginRRR.R..SEER/CoCRevised
191NHIA Derived Hisp OriginD..DR..NAACCR
192IHS LinkR*...R..NPCR
193Race--NAPIIA(derived API)R...R..NAACCRRevised
200Computed EthnicityR..DR..SEER
210Computed Ethnicity SourceR..RR..SEER
220SexRRRRRRRSEER/CoC
230Age at DiagnosisRRRRRDDSEER/CoC
240Date of BirthRRRRRRRSEER/CoC
241Date of Birth FlagR.RRR..NAACCRRevised
250BirthplaceRH*......SEER/CoC
252Birthplace--StateR*RRRRRRNAACCR
254Birthplace--CountryR*RRRRRRNAACCR
260ReligionRetired
270Census Occ Code 1970-2000R*......Census/NPCR
272Census Ind Code 2010 CDCR*......Census/NPCR
280Census Ind Code 1970-2000R*......Census/NPCR
282Census Occ Code 2010 CDCR*......Census/NPCR
290Occupation SourceR*......NPCR
300Industry SourceR*......NPCR
310Text--Usual OccupationR*......NPCR
320Text--Usual IndustryR*......NPCR
330Census Occ/Ind Sys 70-00R*......NPCR
339RUCA 2000D..DR..NAACCR
340Tobacco HistoryRetired
341RUCA 2010D..DR..NAACCR
345URIC 2000D..DR..NAACCR
346URIC 2010D..DR..NAACCR
350Alcohol HistoryRetired
351GeoLocationID - 1970/80/90D......NAACCR
352GeoLocationID - 2000D......NAACCR
353GeoLocationID - 2010D......NAACCR
354GeoLocationID - 2020D......NAACCR
360Family History of CancerRetired
361Census Block Group 2020.......Census
362Census Block Group 2000...S...Census
363Census Block Group 2010...R...Census
364Census Tr Cert 1970/80/90RH*..RHRH..SEER
365Census Tr Certainty 2000RH..RHRH..NAACCR
366GIS Coordinate QualityR*..S...NAACCR
367Census Tr Certainty 2010R..RR..NAACCR
368Census Block Grp 1970/80/90...S...Census
369Census Tract Certainty 2020D......NAACCR
370Reserved 01Retired
380Sequence Number--CentralR..RRDDSEER
390Date of DiagnosisRRRRRRR*SEER/CoC
391Date of Diagnosis FlagR..RR..NAACCR
400Primary SiteRRRRRRRSEER/CoC
410LateralityRRRRRRRSEER/CoC
419Morph--Type&Behav ICD-O-2.......
420Histology (92-00) ICD-O-2RHRHRHRHRHRHRHSEER/CoC
430Behavior (92-00) ICD-O-2RHRHRHRHRHRHRHSEER/CoC
439Date of Mult Tumors Flag.RHRHRHRH..NAACCR
440GradeRHRHRHRHRHRHRHSEER/CoC
441Grade Path ValueRH*RHRHRHRH..AJCCRevised
442Ambiguous Terminology DX.RHRHRHRH..SEER
443Date Conclusive DX.RHRHRHRH..SEER
444Mult Tum Rpt as One Prim.RHRHRHRH..SEER
445Date of Mult Tumors.RHRHRHRH..SEER
446Multiplicity Counter.RHRHRHRH..SEER
447Number of Tumors/HistRetired
448Date Conclusive DX Flag.RHRHRHRH..NAACCR
449Grade Path SystemRH*RHRHRHRH..AJCCRevised
450Site Coding Sys--CurrentR.R....NAACCRRevised
460Site Coding Sys--Original..R..R*R*NAACCRRevised
470Morph Coding Sys--CurrentR.R....NAACCRRevised
480Morph Coding Sys--Originl..R..R*R*NAACCRRevised
490Diagnostic ConfirmationRRRRRRRSEER/CoC
500Type of Reporting SourceR..RR..SEER
501Casefinding SourceR*......NAACCR
510Screening DateRetired
520Screening ResultRetired
521Morph--Type&Behav ICD-O-3.......
522Histologic Type ICD-O-3RRRRRRRSEER/CoC
523Behavior Code ICD-O-3RRRRRRRSEER/CoC
530Reserved 02Retired
538Reporting Hospital FANRetired
540Reporting FacilityRRRR...CoC
545NPI--Reporting FacilityR*RRR*...CMS
550Accession Number--Hosp.RRR...CoC
560Sequence Number--Hospital.RRR...CoC
570Abstracted By.RRR...CoC
580Date of 1st ContactRRR....CoC
581Date of 1st Contact FlagRRR....NAACCR
590Date of Inpt Adm.......NAACCR
591Date of Inpt Adm Flag.......NAACCR
600Date of Inpt Disch.......NAACCR
601Date of Inpt Disch Flag.......NAACCR
605Inpatient Status.......NAACCR
610Class of CaseRRRRC...CoC
620Year First Seen This CARetired
630Primary Payer at DXR*RRRR..CoC
640Inpatient/Outpt StatusRetired
650Presentation at CA ConfRetired
660Date of CA ConferenceRetired
665RX Hosp--ASA ClassRetired
668RX Hosp--Surg App 2010.RR....CoC
670RX Hosp--Surg Prim Site.RRR...CoC
672RX Hosp--Scope Reg LN Sur.RRR...CoC
674RX Hosp--Surg Oth Reg/Dis.RRR...CoC
676RX Hosp--Reg LN Removed.RHRH....CoC
678RX Hosp--Surg TimingRetired
680Reserved 03Retired
682Date Regional Lymph Node Dissection.RRRCRC..NAACCR
683Date Regional Lymph Node Dissection Flag..RR*RC..NAACCRRevised
690RX Hosp--Radiation...RH...SEER
700RX Hosp--Chemo.RRR...CoC
710RX Hosp--Hormone.RRR...CoC
720RX Hosp--BRM.RRR...CoC
730RX Hosp--Other.RRR...CoC
740RX Hosp--DX/Stg Proc.RR....CoC
742RX Hosp--Screen/BX Proc1Retired
743RX Hosp--Screen/BX Proc2Retired
744RX Hosp--Screen/BX Proc3Retired
745RX Hosp--Screen/BX Proc4Retired
746RX Hosp--Surg Site 98-02.RHRHRH...CoC
747RX Hosp--Scope Reg 98-02.RHRHRH...CoC
748RX Hosp--Surg Oth 98-02.RHRHRH...CoC
750Reserved 04Retired
752Tumor Size Clinical...RRR*R*SEER
754Tumor Size Pathologic...RRR*R*SEER
756Tumor Size SummaryRRRSS..NPCR/CoC
759SEER Summary Stage 2000RHRHRHRHRH..SEER
760SEER Summary Stage 1977RHRHRH.S..SEER
762Derived Summary Stage 2018...DR..SEER
764Summary Stage 2018R.RR*R*..SEERRevised
770Loc/Reg/Distant StageRetired
772EOD Primary Tumor...RR..SEER
774EOD Regional Nodes...RR..SEER
776EOD Mets...RR..SEER
779Extent of Disease 10-Dig.......
780EOD--Tumor Size.RHRHRHRH..SEER/CoC
785Derived EOD 2018 T...DR..SEER
790EOD--Extension...RHRH..SEER
795Derived EOD 2018 M...DR..SEER
800EOD--Extension Prost Path...RHRH..SEER
810EOD--Lymph Node Involv...RHRH..SEER
815Derived EOD 2018 N...DR..SEER
818Derived EOD 2018 Stage Group...DR..SEER
820Regional Nodes PositiveRRRRRR*R*SEER/CoC
830Regional Nodes ExaminedRRRRRR*R*SEER/CoC
832Date of Sentinel Lymph Node Biopsy.RSRSR*R*..CoC
833Date of Sentinel Lymph Node Biopsy Flag..RSR*R*..SEERRevised
834Sentinel Lymph Nodes Examined.RSRSR*R*..CoC
835Sentinel Lymph Nodes Positive.RSRSR*R*..CoC
840EOD--Old 13 Digit...RHRH..SEER
850EOD--Old 2 Digit...RHRH..SEER
860EOD--Old 4 Digit...RHRH..SEER
870Coding System for EOD...RHRH..SEER
880TNM Path T.RHRHRHRH..AJCCRevised
890TNM Path N.RHRHRHRH..AJCCRevised
900TNM Path M.RHRHRHRH..AJCCRevised
910TNM Path Stage Group.RHRHRH*RH*..AJCCRevised
920TNM Path Descriptor.RHRHRHRH..CoCRevised
930TNM Path Staged By.RHRHRHRH..CoC
940TNM Clin T.RHRHRHRH..AJCCRevised
950TNM Clin N.RHRHRHRH..AJCCRevised
960TNM Clin M.RHRHRHRH..AJCCRevised
970TNM Clin Stage Group.RHRHRH*RH*..AJCCRevised
980TNM Clin Descriptor.RHRHRHRH..CoCRevised
990TNM Clin Staged By.RHRHRHRH..CoC
995AJCC IDDDRRCRCR*R*NAACCR
1000TNM Other TRetired
1001AJCC TNM Clin T.RRRC.R*R*AJCC
1002AJCC TNM Clin N.RRRC.R*R*AJCC
1003AJCC TNM Clin M.RRRC.R*R*AJCC
1004AJCC TNM Clin Stage Group.RRRC.R*R*AJCC
1010TNM Other NRetired
1011AJCC TNM Path T.RRRC.R*R*AJCC
1012AJCC TNM Path N.RRRC.R*R*AJCC
1013AJCC TNM Path M.RRRC.R*R*AJCC
1014AJCC TNM Path Stage Group.RRRC.R*R*AJCC
1020TNM Other MRetired
1021AJCC TNM Post Therapy Path (yp) T.RRRC.R*R*AJCCRevised
1022AJCC TNM Post Therapy Path (yp) N.RRRC.R*R*AJCCRevised
1023AJCC TNM Post Therapy Path (yp) M.RRRC.R*R*AJCCRevised
1024AJCC TNM Post Therapy Path (yp) Stage Group.RRRC.R*R*AJCCRevised
1030TNM Other Stage GroupRetired
1031AJCC TNM Clin T Suffix.RRRC.R*R*AJCC
1032AJCC TNM Path T Suffix.RRRC.R*R*AJCC
1033AJCC TNM Post Therapy Path (yp) T Suffix.RRRC.R*R*AJCCRevised
1034AJCC TNM Clin N Suffix.RRRC.R*R*AJCC
1035AJCC TNM Path N Suffix.RRRC.R*R*AJCC
1036AJCC TNM Post Therapy Path (yp) N Suffix.RRRC.R*R*AJCCRevised
1040TNM Other Staged ByRetired
1050TNM Other DescriptorRetired
1060TNM Edition Number.RRRHRHRRCoCRevised
1062AJCC TNM Post Therapy Clin (yc) T.RRC.AJCCNew
1063AJCC TNM Post Therapy Clin (yc) T Suffix.RRC.AJCCNew
1064AJCC TNM Post Therapy Clin (yc) N.RRC.AJCCNew
1065AJCC TNM Post Therapy Clin (yc) N Suffix.RRC.AJCCNew
1066AJCC TNM Post Therapy Clin (yc) M.RRC.AJCCNew
1067AJCC TNM Post Therapy Clin (yc) Stage Group....AJCCNew
1068Grade Post Therapy Clin (yc)R*RRS.NAACCRNew
1070Other Staging SystemRetired
1080Date of 1st Positive BXRetired
1090Site of Distant Met 1Retired
1100Site of Distant Met 2Retired
1110Site of Distant Met 3Retired
1112Mets at DX-Bone.RRRRRRSEER
1113Mets at DX-Brain.RRRRRRSEER
1114Mets at Dx-Distant LN.RRRRRRSEER
1115Mets at DX-Liver.RRRRRRSEER
1116Mets at DX-Lung.RRRRRRSEER
1117Mets at DX-Other.RRRRRRSEER
1120Pediatric Stage.......CoC
1130Pediatric Staging System.......CoC
1140Pediatric Staged By.......CoC
1150Tumor Marker 1.RHRHRHRH..SEER
1160Tumor Marker 2.RHRHRHRH..SEER
1170Tumor Marker 3.RHRHRHRH..SEER
1180Reserved 05Retired
1182Lymphovascular InvasionR*RRRSRSR*R*AJCC
1190Reserved 06Retired
1200RX Date SurgeryRRRRCRC..CoC
1201RX Date Surgery FlagRRRRCRC..NAACCR
1210RX Date RadiationRRRRCRC..CoC
1211RX Date Radiation FlagR.RR*RC..NAACCRRevised
1220RX Date ChemoRRRRCRC..CoC
1221RX Date Chemo FlagR.RRCRC..NAACCRRevised
1230RX Date HormoneRRRRCRC..CoC
1231RX Date Hormone FlagRRRRCRC..NAACCR
1240RX Date BRMRRRRCRC..CoC
1241RX Date BRM FlagRRRRCRC..NAACCR
1250RX Date OtherRRRRCRC..CoC
1251RX Date Other FlagR.RR*RC..NAACCRRevised
1260Date Initial RX SEERR#..RR..SEER
1261Date Initial RX SEER FlagR#..RR..NAACCR
1270Date 1st Crs RX CoCR#RR....CoC
1271Date 1st Crs RX CoC FlagR#.R....NAACCRRevised
1280RX Date DX/Stg Proc.RR....CoC
1281RX Date DX/Stg Proc Flag.RR....NAACCR
1285RX Summ--Treatment StatusR#RRRR..SEER/CoC
1290RX Summ--Surg Prim SiteRRRRR..SEER/CoC
1292RX Summ--Scope Reg LN SurRRRRR..SEER/CoC
1294RX Summ--Surg Oth Reg/DisRRRRR..SEER/CoC
1296RX Summ--Reg LN Examined.RHRHRHRH..SEER/CoC
1300Reserved 07Retired
1310RX Summ--Surgical Approch.RHRH....CoC
1320RX Summ--Surgical Margins.RRR*R*..CoC
1330RX Summ--Reconstruct 1st.RHRH.RH..SEERRevised
1340Reason for No SurgeryRRRRR..SEER/CoC
1350RX Summ--DX/Stg Proc.RR....CoC
1360RX Summ--RadiationRH..RHRH..SEER
1370RX Summ--Rad to CNS...RHRH..SEER/CoC
1380RX Summ--Surg/Rad SeqRRRRR..SEER/CoC
1390RX Summ--ChemoRRRRR..SEER/CoC
1400RX Summ--HormoneRRRRR..SEER/CoC
1410RX Summ--BRMRRRRR..SEER/CoC
1420RX Summ--OtherRRRRR..SEER/CoC
1430Reason for No RadiationRRRRR..CoC
1440Reason for No ChemoRetired
1450Reason for No HormoneRetired
1460RX Coding System--CurrentR.R.RH..NAACCRRevised
1470Protocol Eligibility StatRetired
1480Protocol ParticipationRetired
1490Referral to Support ServRetired
1500First Course Calc MethodRetired
1501Phase I Dose per Fraction.RRR*R*..CoC
1502Phase I Radiation External Beam Planning Tech.RRRCRC..CoC
1503Phase I Number of Fractions.RRR*R*..CoC
1504Phase I Radiation Primary Treatment Volume.RRR*R*..CoC
1505Phase I Radiation to Draining Lymph Nodes.RRR*R*..CoC
1506Phase I Radiation Treatment ModalityRRRRR..CoC
1507Phase I Total Dose.RRR*R*..CoC
1510Rad--Regional Dose: cGy.......CoC
1511Phase II Dose per Fraction.RRR*R*..CoC
1512Phase II Radiation External Beam Planning Tech.RRRCRC..CoC
1513Phase II Number of Fractions.RRR*R*..CoC
1514Phase II Radiation Primary Treatment Volume.RRR*R*..CoC
1515Phase II Radiation to Draining Lymph Nodes.RRR*R*..CoC
1516Phase II Radiation Treatment Modality.RRRR..CoC
1517Phase II Total Dose.RRR*R*..CoC
1520Rad--No of Treatment Vol.......CoC
1521Phase III Dose per Fraction.RRR*R*..CoC
1522Phase III Radiation External Beam Planning Tech.RRRCRC..CoC
1523Phase III Number of Fractions.RRR*R*..CoC
1524Phase III Radiation Primary Treatment Volume.RRR*R*..CoC
1525Phase III Radiation to Draining Lymph Nodes.RRR*R*..CoC
1526Phase III Radiation Treatment Modality.RRRR..CoC
1527Phase III Total Dose.RRR*R*..CoC
1530Rad--Elapsed RX DaysRetired
1531Radiation Treatment Discontinued Early.RRR*R*..CoC
1532Number of Phases of Rad Treatment to this Volume.RRR*R*..CoC
1533Total Dose.RRR*R*..CoC
1540Rad--Treatment Volume.......CoC
1550Rad--Location of RX.RR....CoC
1560Rad--Intent of TreatmentRetired
1570Rad--Regional RX ModalityRH......CoC
1580Rad--RX Completion StatusRetired
1590Rad--Local Control StatusRetired
1600Chemotherapy Field 1Retired
1610Chemotherapy Field 2Retired
1620Chemotherapy Field 3Retired
1630Chemotherapy Field 4Retired
1632Neoadjuvant Therapy..R.SEERNew
1633Neoadjuvant Therapy-Clinical Response..R.SEERNew
1634Neoadjuvant Therapy-Treatment Effect..R.SEERNew
1639RX Summ--Systemic/Sur SeqRRRRR..CoC
1640RX Summ--Surgery Type...RHRH..SEER
1642RX Summ--Screen/BX Proc1Retired
1643RX Summ--Screen/BX Proc2Retired
1644RX Summ--Screen/BX Proc3Retired
1645RX Summ--Screen/BX Proc4Retired
1646RX Summ--Surg Site 98-02.RHRH.RH..SEER/CoCRevised
1647RX Summ--Scope Reg 98-02.RHRHRHRH..SEER/CoC
1648RX Summ--Surg Oth 98-02.RHRHRHRH..SEER/CoC
1650Reserved 08Retired
1660Subsq RX 2nd Course Date.......CoC
1661Subsq RX 2ndCrs Date Flag.......NAACCR
1670Subsq RX 2nd Course Codes.......
1671Subsq RX 2nd Course Surg.......CoC
1672Subsq RX 2nd Course Rad.......CoC
1673Subsq RX 2nd Course Chemo.......CoC
1674Subsq RX 2nd Course Horm.......CoC
1675Subsq RX 2nd Course BRM.......CoC
1676Subsq RX 2nd Course Oth.......CoC
1677Subsq RX 2nd--Scope LN SU.......CoC
1678Subsq RX 2nd--Surg Oth.......CoC
1679Subsq RX 2nd--Reg LN Rem.......CoC
1680Subsq RX 3rd Course Date.......CoC
1681Subsq RX 3rdCrs Date Flag.......NAACCR
1690Subsq RX 3rd Course Codes.......
1691Subsq RX 3rd Course Surg.......CoC
1692Subsq RX 3rd Course Rad.......CoC
1693Subsq RX 3rd Course Chemo.......CoC
1694Subsq RX 3rd Course Horm.......CoC
1695Subsq RX 3rd Course BRM.......CoC
1696Subsq RX 3rd Course Oth.......CoC
1697Subsq RX 3rd--Scope LN Su.......CoC
1698Subsq RX 3rd--Surg Oth.......CoC
1699Subsq RX 3rd--Reg LN Rem.......CoC
1700Subsq RX 4th Course Date.......CoC
1701Subsq RX 4thCrs Date Flag.......NAACCR
1710Subsq RX 4th Course Codes.......
1711Subsq RX 4th Course Surg.......CoC
1712Subsq RX 4th Course Rad.......CoC
1713Subsq RX 4th Course Chemo.......CoC
1714Subsq RX 4th Course Horm.......CoC
1715Subsq RX 4th Course BRM.......CoC
1716Subsq RX 4th Course Oth.......CoC
1717Subsq RX 4th--Scope LN Su.......CoC
1718Subsq RX 4th--Surg Oth.......CoC
1719Subsq RX 4th--Reg LN Rem.......CoC
1720Subsq RX 5th Course DateRetired
1730Subsq RX 5th Course CodesRetired
1731Subsq RX 5th Course SurgRetired
1732Subsq RX 5th Course RadRetired
1733Subsq RX 5th Course ChemoRetired
1734Subsq RX 5th Course HormRetired
1735Subsq RX 5th Course BRMRetired
1736Subsq RX 5th Course OthRetired
1737Subsq RX 5th--Scope LN SuRetired
1738Subsq RX 5th--Surg OthRetired
1739Subsq RX 5th--Reg LN RemRetired
1740Reserved 09Retired
1741Subsq RX--Reconstruct Del.......CoC
1750Date of Last ContactRRRRR..SEER/CoC
1751Date of Last Contact FlagR.RRR..NAACCRRevised
1755Date of Death--Canada.....R*R*CCCR
1756Date of Death--CanadaFlag.......NAACCR
1760Vital StatusRRRRRDDSEER/CoC
1762Vital Status RecodeD..DR..NAACCR
1770Cancer Status.RR....CoC
1772Date of Last Cancer (tumor) Status .RR....CoC
1773Date of Last Cancer (tumor) Status Flag.R....NAACCRRevised
1775Record Number RecodeD..DR..NAACCRRevised
1780Quality of Survival.......CoC
1782Surv-Date Active FollowupD..DR..NAACCRRevised
1783Surv-Flag Active FollowupD..DR..NAACCRRevised
1784Surv-Mos Active FollowupD..DR..NAACCRRevised
1785Surv-Date Presumed AliveD..DR..NAACCR
1786Surv-Flag Presumed AliveD..DR..NAACCR
1787Surv-Mos Presumed AliveD..DR..NAACCR
1788Surv-Date DX RecodeD..DR..NAACCR
1790Follow-Up SourceR*R.....CoC
1791Follow-up Source CentralR......NAACCR
1800Next Follow-Up Source.R.....CoC
1810Addr Current--City...R...SEERRevised
1820Addr Current--State...R...SEERRevised
1830Addr Current--Postal Code...R...SEERRevised
1832Addr Current--Country...R...NAACCRRevised
1835Reserved 10Retired
1840County--Current.......NAACCR
1842Follow-Up Contact--City.......SEER
1844Follow-Up Contact--State.......SEER
1846Follow-Up Contact--Postal.......SEER
1847FollowUp Contact--Country.......NAACCR
1850Unusual Follow-Up Method.......NAACCR
1860Recurrence Date--1st.RRRC...CoC
1861Recurrence Date--1st Flag..RR*...NAACCRRevised
1870Recurrence Distant SitesRetired
1871Recurrence Distant Site 1Retired
1872Recurrence Distant Site 2Retired
1873Recurrence Distant Site 3Retired
1880Recurrence Type--1st.RRRC...CoC
1890Recurrence Type--1st--OthRetired
1900Reserved 11Retired
1910Cause of DeathR..RRR*R*SEER
1914SEER Cause Specific CODD..DR..SEER
1915SEER Other CODD..DR..SEER
1920ICD Revision NumberR..RR..SEER
1930Autopsy.......NAACCR
1940Place of DeathRH....R*R*NPCR
1942Place of Death--StateR..RRDDNAACCR
1944Place of Death--CountryR*..RRDDNAACCR
1960Site (73-91) ICD-O-1...RHRH..SEER
1970Morph (73-91) ICD-O-1.......
1971Histology (73-91) ICD-O-1...RHRH..SEER
1972Behavior (73-91) ICD-O-1...RHRH..SEER
1973Grade (73-91) ICD-O-1...RHRH..SEER
1980ICD-O-2 Conversion Flag..RHRR..SEERRevised
1981Over-ride SS/NodesPos...RHRH..NAACCR
1982Over-ride SS/TNM-N...RHRH..NAACCR
1983Over-ride SS/TNM-M...RHRH..NAACCR
1984Over-ride SS/DisMet1Retired
1985Over-ride Acsn/Class/Seq..R....NAACCRRevised
1986Over-ride HospSeq/DxConf..R....NAACCRRevised
1987Over-ride CoC-Site/Type..R....NAACCRRevised
1988Over-ride HospSeq/Site..R....NAACCRRevised
1989Over-ride Site/TNM-StgGrp..RRR..NAACCRRevised
1990Over-ride Age/Site/MorphR.RRR..SEERRevised
1992Over-ride TNM Stage.......NAACCRRevised
1993Over-ride TNM Tis...RR..NAACCRRevised
1994Over-ride TNM 3.......NAACCR
2000Over-ride SeqNo/DxConfR..RR..SEER
2010Over-ride Site/Lat/SeqNoR..RR..SEER
2020Over-ride Surg/DxConfR.RRR..SEERRevised
2030Over-ride Site/TypeR.RRR..SEERRevised
2040Over-ride HistologyR.RRR..SEERRevised
2050Over-ride Report SourceR..RR..SEER
2060Over-ride Ill-define SiteR..RR..SEER
2070Over-ride Leuk, LymphomaR.RRR..SEERRevised
2071Over-ride Site/BehaviorR.RRR..SEERRevised
2072Over-ride Site/EOD/DX Dt...RR..SEER
2073Over-ride Site/Lat/EOD...RR..SEER
2074Over-ride Site/Lat/MorphR.RRR..SEERRevised
2078Over-ride Name/SexR..RR..NAACCR
2080Reserved 13Retired
2081CRC CHECKSUM...SS..NAACCR
2085Date Case Initiated.......NAACCR
2090Date Case Completed.......NAACCR
2092Date Case Completed--CoC.DD....CoC
2100Date Case Last Changed.DD....NAACCR
2110Date Case Report ExportedR......NPCR
2111Date Case Report ReceivedR......NPCR
2112Date Case Report LoadedR......NPCR
2113Date Tumor Record AvailblR......NPCR
2114Future Use Timeliness 1Retired
2115Future Use Timeliness 2Retired
2116ICD-O-3 Conversion FlagR..RR..SEERRevised
2117Schema ID Version CurrentDDDR*SEERNew
2118Schema ID Version OriginalDDDR*SEERNew
2120SEER Coding Sys--Current....R..NAACCR
2130SEER Coding Sys--Original....R..NAACCR
2140CoC Coding Sys--Current..R....CoCRevised
2150CoC Coding Sys--Original..R....CoCRevised
2152CoC Accredited FlagR..RR..NPCR
2155RQRS NCDB Submission Flag..R....CoCRevised
2156AJCC API Version Current.DD*R*AJCCNew
2157AJCC API Version Original.DD*R*AJCCNew
2158AJCC Cancer Surveillance API Version CurrentDDD*R*AJCCNew
2159AJCC Cancer Surveillance API Version OriginalDDD*R*AJCCNew
2160Subsq Report for PrimaryRetired
2161Reserved 18Retired
2162Reserved 19Retired
2163Reserved 20Retired
2170Vendor Name.RR....NAACCR
2180SEER Type of Follow-Up....R..SEERRevised
2190SEER Record Number....R..SEER
2200Diagnostic Proc 73-87....RH..SEERRevised
2210Reserved 14Retired
2220State/Requestor Items.......Varies
2230Name--LastR..R.RRSEERRevised
2232Name--Birth SurnameR.RR*NAACCRNew
2240Name--FirstR..R.R*R*SEERRevised
2250Name--MiddleR..R.R*R*SEERRevised
2260Name--Prefix.......NAACCR
2270Name--Suffix...R...NAACCR
2280Name--AliasR..R...NAACCR
2290Name--Spouse/Parent.......NAACCR
2300Medical Record NumberR..R...NAACCRRevised
2310Military Record No Suffix.......CoC
2315Medicare Beneficiary IdentifierR*...NAACCRRevised
2320Social Security NumberR..R...SEERRevised
2330Addr at DX--No & StreetR..R...SEERRevised
2335Addr at DX--SupplementlR..R...SEERRevised
2350Addr Current--No & Street...R...SEERRevised
2352LatitudeR*..S...NAACCR
2354LongitudeR*..S...NAACCR
2355Addr Current--Supplementl...R*...SEERRevised
2360Telephone...R...SEERRevised
2370DC StateRetired
2380DC State File NumberR..R*...State
2390Name--Maiden.....R*R*NAACCRRevised
2392Follow-Up Contact--No&St.......SEER
2393Follow-Up Contact--Suppl.......SEER
2394Follow-Up Contact--Name.......SEER
2400Reserved 15Retired
2410Institution Referred From.......CoC
2415NPI--Inst Referred From.R.....CMS
2420Institution Referred To.......CoC
2425NPI--Inst Referred To.R.....CMS
2430Last Follow-Up HospitalRetired
2440Following Registry...RH...CoC
2445NPI--Following Registry...RH*...CMS
2450Reserved 16Retired
2460Physician--Managing.......NAACCR
2465NPI--Physician--Managing.......CMSRevised
2470Physician--Follow-Up...R...CoC
2475NPI--Physician--Follow-Up...R*...CMSRevised
2480Physician--Primary Surg.......CoC
2485NPI--Physician--Primary Surg.RR....CMS
2490Physician 3.......CoC
2495NPI--Physician 3.RR....CMS
2500Physician 4.......CoC
2505NPI--Physician 4.RR....CMS
2508EHR Reporting.......NAACCR
2510Reserved 12Retired
2520Text--DX Proc--PER^..R...NPCR
2530Text--DX Proc--X-ray/ScanR^..R...NPCR
2540Text--DX Proc--ScopesR^..R...NPCR
2550Text--DX Proc--Lab TestsR^..R...NPCR
2560Text--DX Proc--OpR^..R...NPCR
2570Text--DX Proc--PathR^..R...NPCR
2580Text--Primary Site TitleR^..R...NPCR
2590Text--Histology TitleR^..R...NPCR
2600Text--StagingR^..R...NPCR
2610RX Text--SurgeryR^..R...NPCR
2620RX Text--Radiation (Beam)R^..R...NPCR
2630RX Text--Radiation OtherR^..R...NPCR
2640RX Text--ChemoR^..R...NPCR
2650RX Text--HormoneR^..R...NPCR
2660RX Text--BRMR^..R...NPCR
2670RX Text--OtherR^..R...NPCR
2680Text--Remarks...R...NPCR
2690Text--Place of Diagnosis.......NPCR
2700Reserved 17Retired
2730CS PreRx Tumor SizeRetired
2735CS PreRx ExtensionRetired
2740CS PreRx Tum Sz/Ext EvalRetired
2750CS PreRx Lymph NodesRetired
2755CS PreRx Reg Nodes EvalRetired
2760CS PreRx Mets at DXRetired
2765CS PreRx Mets EvalRetired
2770CS PostRx Tumor SizeRetired
2775CS PostRx ExtensionRetired
2780CS PostRx Lymph NodesRetired
2785CS PostRx Mets at DXRetired
2800CS Tumor SizeRH*RHRHRH*RH*RH*RH*AJCC
2810CS ExtensionRH*RHRHRH*RH*RH*RH*AJCC
2820CS Tumor Size/Ext EvalRH*RHRHRH*RH*RH*RH*AJCC
2830CS Lymph NodesRH*RHRHRH*RH*RH*RH*AJCC
2840CS Lymph Nodes EvalRH*RHRHRH*RH*RH*RH*AJCC
2850CS Mets at DXRH*RHRHRH*RH*RH*RH*AJCC
2851CS Mets at Dx-Bone.RHRHRHRHRH*RH*AJCC
2852CS Mets at Dx-Brain.RHRHRHRHRH*RH*AJCC
2853CS Mets at Dx-Liver.RHRHRHRHRH*RH*AJCC
2854CS Mets at Dx-Lung.RHRHRHRHRH*RH*AJCC
2860CS Mets EvalRH*RHRHRH*RH*RH*RH*AJCC
2861CS Site-Specific Factor 7RH*RHRHRHRHRH*RH*AJCC
2862CS Site-Specific Factor 8RH*RHRHRHRHRH*RH*AJCC
2863CS Site-Specific Factor 9RH*RHRHRHRHRH*RH*AJCC
2864CS Site-Specific Factor10RH*RHRHRHRHRH*RH*AJCC
2865CS Site-Specific Factor11RH*RHRHRHRHRH*RH*AJCC
2866CS Site-Specific Factor12RH*RHRHRHRHRH*RH*AJCC
2867CS Site-Specific Factor13RH*RHRHRHRHRH*RH*AJCC
2868CS Site-Specific Factor14RH*RHRHRHRHRH*RH*AJCC
2869CS Site-Specific Factor15RH*RHRHRHRHRH*RH*AJCC
2870CS Site-Specific Factor16RH*RHRHRHRHRH*RH*AJCC
2871CS Site-Specific Factor17RH*RHRHRHRHRH*RH*AJCC
2872CS Site-Specific Factor18.RHRHRHRHRH*RH*AJCC
2873CS Site-Specific Factor19.RHRHRHRHRH*RH*AJCC
2874CS Site-Specific Factor20.RHRHRHRHRH*RH*AJCC
2875CS Site-Specific Factor21.RHRHRHRHRH*RH*AJCC
2876CS Site-Specific Factor22.RHRHRHRHRH*RH*AJCC
2877CS Site-Specific Factor23.RHRHRHRHRH*RH*AJCC
2878CS Site-Specific Factor24.RHRHRHRHRH*RH*AJCC
2879CS Site-Specific Factor25RH*RHRHRHRHRH*RH*AJCC
2880CS Site-Specific Factor 1RH*RHRHRHRHRH*RH*AJCC
2890CS Site-Specific Factor 2RH*RHRHRHRHRH*RH*AJCC
2900CS Site-Specific Factor 3RH*RHRHRHRHRH*RH*AJCC
2910CS Site-Specific Factor 4RH*RHRHRHRHRH*RH*AJCC
2920CS Site-Specific Factor 5RH*RHRHRHRHRH*RH*AJCC
2930CS Site-Specific Factor 6RH*RHRHRHRHRH*RH*AJCC
2935CS Version Input OriginalR*RHRHRH*RH*RH*RH*AJCC
2936CS Version DerivedRH*DHDHD*DH*DHDHAJCC
2937CS Version Input CurrentR*RHRHRH*RH*RH*RH*AJCC
2940Derived AJCC-6 T.DHDHDHRHDHDHAJCC
2950Derived AJCC-6 T Descript.DHDHDHRHDHDHAJCC
2960Derived AJCC-6 N.DHDHDHRHDHDHAJCC
2970Derived AJCC-6 N Descript.DHDHDHRHDHDHAJCC
2980Derived AJCC-6 M.DHDHDHRHDHDHAJCC
2990Derived AJCC-6 M Descript.DHDHDHRHDHDHAJCC
3000Derived AJCC-6 Stage Grp.DHDHDHRHDHDHAJCC
3010Derived SS1977.DHDHD*SDHDHAJCC
3020Derived SS2000RH*DHDHD+R+DHDHAJCC
3030Derived AJCC--Flag.DHDHDHRH..AJCC
3040Derived SS1977--Flag.DHDHD*S..AJCC
3050Derived SS2000--FlagRH*DHDHD*S..AJCC
3100Archive FIN.RR....CoC
3105NPI--Archive FIN.RR....CMS
3110Comorbid/Complication 1.RHRH....CoC
3120Comorbid/Complication 2.RHRH....CoC
3130Comorbid/Complication 3.RHRH....CoC
3140Comorbid/Complication 4.RHRH....CoC
3150Comorbid/Complication 5.RHRH....CoC
3160Comorbid/Complication 6.RHRH....CoC
3161Comorbid/Complication 7.RHRH....CoC
3162Comorbid/Complication 8.RHRH....CoC
3163Comorbid/Complication 9.RHRH....CoC
3164Comorbid/Complication 10.RHRH....CoC
3165ICD Revision Comorbid.......CoC
3170RX Date Mst Defn SrgRRRRCRC..CoC
3171RX Date Mst Defn Srg FlagR.RR*RC..NAACCRRevised
3180RX Date Surg Disch.RR....CoC
3181RX Date Surg Disch Flag..R....NAACCRRevised
3190Readm Same Hosp 30 Days.RR....CoC
3200Rad--Boost RX Modality.......CoC
3210Rad--Boost Dose cGy.......CoC
3220RX Date Rad Ended.RR....CoC
3221RX Date Rad Ended Flag..R....NAACCRRevised
3230RX Date Systemic.RRRCRC..CoC
3231RX Date Systemic Flag..RR*RC..NAACCRRevised
3250RX Summ--Transplnt/EndocrRRRRR..CoC
3260Pain AssessmentRetired
3270RX Summ--Palliative Proc.RR....CoC
3280RX Hosp--Palliative Proc.RR....CoC
3300RuralUrban Continuum 1993D......NAACCR
3310RuralUrban Continuum 2003D......NAACCR
3312RuralUrban Continuum 2013D..DR..NAACCR
3400Derived AJCC-7 TRH*DHDHDHRHDHDHAJCC
3402Derived AJCC-7 T DescriptRH*DHDHDHRHDHDHAJCC
3410Derived AJCC-7 NRH*DHDHDHRHDHDHAJCC
3412Derived AJCC-7 N DescriptRH*DHDHDHRHDHDHAJCC
3420Derived AJCC-7 MRH*DHDHDHRHDHDHAJCC
3422Derived AJCC-7 M DescriptRH*DHDHDHRHDHDHAJCC
3430Derived AJCC-7 Stage GrpRH*DHDHDHRHDHDHAJCC
3440Derived PreRx-7 T.......AJCC
3442Derived PreRx-7 T Descrip.......AJCC
3450Derived PreRx-7 N.......AJCC
3452Derived PreRx-7 N Descrip.......AJCC
3460Derived PreRx-7 M.......AJCC
3462Derived PreRx-7 M Descrip.......AJCC
3470Derived PreRx-7 Stage Grp.......AJCC
3480Derived PostRx-7 T.......AJCC
3482Derived PostRx-7 N.......AJCC
3490Derived PostRx-7 M.......AJCC
3492Derived PostRx-7 Stge Grp.......AJCC
3600Derived Neoadjuv Rx Flag.......AJCC
3605Derived SEER Path Stg Grp...DHRH..SEER
3610Derived SEER Clin Stg Grp...DHRH..SEER
3614Derived SEER Cmb Stg Grp...DHRH..SEER
3616Derived SEER Combined T...DHRH..SEER
3618Derived SEER Combined N...DHRH..SEER
3620Derived SEER Combined M...DHRH..SEER
3622Derived SEER Cmb T Src...DHRH..SEER
3624Derived SEER Cmb N Src...DHRH..SEER
3626Derived SEER Cmb M Src...DHRH..SEER
3645NPCR Derived AJCC 8 TNM Clin Stg Grp.....R*R*NPCR
3646NPCR Derived AJCC 8 TNM Path Stg Grp.....R*R*NPCR
3647NPCR Derived AJCC 8 TNM Post Therapy Stg Grp.....R*R*NPCR
3650NPCR Derived Clin Stg Grp.......NPCRRevised
3655NPCR Derived Path Stg Grp.......NPCRRevised
3700SEER Site-Specific Fact 1...RR..SEER
3702SEER Site-Specific Fact 2.......SEER
3704SEER Site-Specific Fact 3.......SEER
3706SEER Site-Specific Fact 4.......SEER
3708SEER Site-Specific Fact 5.......SEER
3710SEER Site-Specific Fact 6.......SEER
3720NPCR Specific FieldR......NPCR
3750Over-ride CS 1.RHRH....AJCC
3751Over-ride CS 2.RHRH....AJCC
3752Over-ride CS 3.RHRH....AJCC
3753Over-ride CS 4.RHRH....AJCC
3754Over-ride CS 5.RHRH....AJCC
3755Over-ride CS 6.RHRH....AJCC
3756Over-ride CS 7.RHRH....AJCC
3757Over-ride CS 8.RHRH....AJCC
3758Over-ride CS 9.RHRH....AJCC
3759Over-ride CS 10.RHRH....AJCC
3760Over-ride CS 11.RHRH....AJCC
3761Over-ride CS 12.RHRH....AJCC
3762Over-ride CS 13.RHRH....AJCC
3763Over-ride CS 14.RHRH....AJCC
3764Over-ride CS 15.RHRH....AJCC
3765Over-ride CS 16.RHRH....AJCC
3766Over-ride CS 17.RHRH....AJCC
3767Over-ride CS 18.RHRH....AJCC
3768Over-ride CS 19.RHRH....AJCC
3769Over-ride CS 20.RHRHRHRH..AJCC/NPCRRevised
3780Secondary Diagnosis 1.RR....CoC
3782Secondary Diagnosis 2.RR....CoC
3784Secondary Diagnosis 3.RR....CoC
3786Secondary Diagnosis 4.RR....CoC
3788Secondary Diagnosis 5.RR....CoC
3790Secondary Diagnosis 6.RR....CoC
3792Secondary Diagnosis 7.RR....CoC
3794Secondary Diagnosis 8.RR....CoC
3796Secondary Diagnosis 9.RR....CoC
3798Secondary Diagnosis 10.RR....CoC
3800Schema IDDDRDRDRNAACCR
3801Chromosome 1p: Loss of Heterozygosity (LOH).RSRSRSRS..NAACCR
3802Chromosome 19q: Loss of Heterozygosity (LOH).RSRSRSRS..NAACCR
3803Adenoid Cystic Basaloid Pattern.RSRSRSRS..NAACCR
3804Adenopathy.RSRSRSRSRS*RSNAACCRRevised
3805AFP Post-Orchiectomy Lab Value.RSRSRCRC..NAACCR
3806AFP Post-Orchiectomy Range.RSRSRSRS..NAACCR
3807AFP Pre-Orchiectomy Lab Value.RSRSRCRC..NAACCR
3808AFP Pre-Orchiectomy Range.RSRSRCRC..NAACCR
3809AFP Pretreatment Interpretation.RSRSRCRCRS*RSNAACCRRevised
3810AFP Pretreatment Lab Value.RSRSRCRC..NAACCR
3811Anemia.RSRSRSRSRS*RSNAACCRRevised
3812B symptoms.RSRSRSRSRS*RSNAACCRRevised
3813Bilirubin Pretreatment Total Lab Value.RSRSRCRC..NAACCR
3814Bilirubin Pretreatment Unit of Measure.RSRSRCRC..NAACCR
3815Bone Invasion.RSRSRSRS..NAACCR
3816Brain Molecular MarkersR..RSRS..NAACCR
3817Breslow Tumor Thickness RRSRSRSRSRS*RSNAACCRRevised
3818CA-125 Pretreatment Interpretation.RSRSRSRSRS*RSNAACCRRevised
3819CEA Pretreatment Interpretation.RSRSRSRSRS*RSNAACCRRevised
3820CEA Pretreatment Lab Value.RSRSRSRS..NAACCR
3821Chromosome 3 Status.RSRSRCRC..NAACCR
3822Chromosome 8q Status.RSRSRCRC..NAACCR
3823Circumferential Resection Margin (CRM).RSRSRSRSRS*RSNAACCRRevised
3824Creatinine Pretreatment Lab Value.RSRSRCRC..NAACCR
3825Creatinine Pretreatment Unit of Measure.RSRSRCRC..NAACCR
3826Estrogen Receptor Percent Positive or Range .RSRSRCRC..NAACCR
3827Estrogen Receptor SummaryRRSRSRSRSRS*RSNAACCRRevised
3828Estrogen Receptor Total Allred Score .RSRSRCRC..NAACCR
3829Esophagus and EGJ Tumor Epicenter.RSRSRSRSRS*RSNAACCRRevised
3830Extranodal Extension Clin (non-Head and Neck).RSRSRCRC..NAACCR
3831Extranodal Extension Head and Neck Clinical.RSRSRCRC..NAACCR
3832Extranodal Extension Head and Neck Pathological.RSRSRSRSRS*RSNAACCRRevised
3833Extranodal Extension Path (non-Head and Neck).RSRSRCRC..NAACCR
3834Extravascular Matrix Patterns .RSRSRCRC..NAACCR
3835Fibrosis ScoreRRSRSRCRC..NAACCR
3836FIGO Stage.RSRSRSRS..NAACCR
3837Gestational Trophoblastic Prognostic Scoring Index.RSRSRSRSRS*RSNAACCRRevised
3838Gleason Patterns ClinicalRRSRSRSRSRS*RSNAACCRRevised
3839Gleason Patterns PathologicalRRSRSRSRSRS*RS*NAACCRRevised
3840Gleason Score ClinicalRRSRSRCRCRS*RSNAACCRRevised
3841Gleason Score PathologicalRRSRSRCRCRS*RSNAACCRRevised
3842Gleason Tertiary PatternRS*RSRSRCRCRS*RSNAACCRRevised
3843Grade ClinicalRRRRRRRNAACCR
3844Grade PathologicalRRRRRRRNAACCRRevised
3845Grade Post Therapy Path (yp)R*RRRSRSRRNAACCRRevised
3846hCG Post-Orchiectomy Lab Value.RSRSRCRC..NAACCR
3847hCG Post-Orchiectomy Range.RSRSRSRS..NAACCR
3848hCG Pre-Orchiectomy Lab Value.RSRSRCRC..NAACCR
3849hCG Pre-Orchiectomy Range.RSRSRSRS..NAACCR
3850HER2 IHC Summary ....RCRS*RSNAACCRRevised
3851HER2 ISH Dual Probe Copy Number....RC..NAACCRRevised
3852HER2 ISH Dual Probe Ratio....RC..NAACCRRevised
3853HER2 ISH Single Probe Copy Number....RC..NAACCRRevised
3854HER2 ISH Summary....RCRS*RSNAACCRRevised
3855HER2 Overall Summary RSRSRSRSRSRS*RSNAACCRRevised
3856Heritable Trait.RSRSRSRSRS*RSNAACCRRevised
3857High Risk Cytogenetics.RSRSRSRSRS*RSNAACCRRevised
3858High Risk Histologic Features.RSRSRSRS..NAACCR
3859HIV Status..RSRSRS..NAACCRRevised
3860International Normalized Ratio Prothrombin Time.RSRSRCRC..NAACCR
3861Ipsilateral Adrenal Gland Involvement.RSRSRSRS..NAACCR
3862JAK2.RSRSRSRS..NAACCR
3863Ki-67.RSRSRCRC..NAACCR
3864Invasion Beyond Capsule.RSRSRSRS..NAACCR
3865KIT Gene Immunohistochemistry .RSRSRCRCRS*RSNAACCRRevised
3866KRAS.RSRSRSRS..NAACCR
3867LDH Post-Orchiectomy Range.RSRSRSRS..NAACCR
3868LDH Pre-Orchiectomy Range.RSRSRSRS..NAACCR
3869LDH Level.RSRSRSRSRS*RSNAACCRRevised
3870LDH Upper Limits of Normal.RSRSRCRC..NAACCR
3871LN Assessment Method Femoral-Inguinal.RSRSRCRC..NAACCR
3872LN Assessment Method Para-Aortic.RSRSRCRC..NAACCR
3873LN Assessment Method Pelvic.RSRSRCRC..NAACCR
3874LN Distant Assessment Method.RSRSRCRC..NAACCR
3875LN Distant: Mediastinal, Scalene.RSRSRCRC..NAACCR
3876LN Head and Neck Levels I-III.RSRSRSRS..NAACCR
3877LN Head and Neck Levels IV-V.RSRSRSRS..NAACCR
3878LN Head and Neck Levels VI-VII.RSRSRSRS..NAACCR
3879LN Head and Neck Other.RSRSRSRS..NAACCR
3880LN Isolated Tumor Cells (ITC).RSRSRSRS..NAACCR
3881LN Laterality.RSRSRSRS..NAACCR
3882LN Positive Axillary Level I-II.RSRSRSRS..NAACCR
3883LN Size.RSRSRSRSRS*RSNAACCRRevised
3884LN Status Femoral-Inguinal, Para-Aortic, Pelvic.RSRSRSRS..NAACCR
3885Lymphocytosis.RSRSRSRSRS*RSNAACCRRevised
3886Major Vein Involvement.RSRSRSRS..NAACCR
3887Measured Basal Diameter.RSRSRSRS..NAACCR
3888Measured Thickness.RSRSRSRS..NAACCR
3889Methylation of O6-Methylguanine-Methyltransferase.RSRSRSRS..NAACCR
3890Microsatellite Instability (MSI)RS*RSRSRSRSRS*RSNAACCRRevised
3891Microvascular Density .RSRSRCRC..NAACCR
3892Mitotic Count Uveal Melanoma.RSRSRCRC..NAACCR
3893Mitotic Rate Melanoma.RSRSRSRSRS*RSNAACCRRevised
3894Multigene Signature Method.RSRSRSRS..NAACCR
3895Multigene Signature Results.RSRSRSRS..NAACCR
3896NCCN International Prognostic Index (IPI).RSRSRSRS..NAACCR
3897Number of Cores Examined.RSRSRSRSRS*RSNAACCRRevised
3898Number of Cores Positive.RSRSRSRSRS*RSNAACCRRevised
3899Number of Examined Para-Aortic Nodes.RSRSRCRC..NAACCR
3900Number of Examined Pelvic Nodes.RSRSRCRC..NAACCR
3901Number of Positive Para-Aortic Nodes.RSRSRCRC..NAACCR
3902Number of Positive Pelvic Nodes.RSRSRCRC..NAACCR
3903Oncotype Dx Recurrence Score-DCIS.RSRSRCRC..NAACCR
3904Oncotype Dx Recurrence Score-Invasive.RSRSRSRSRS*RSNAACCRRevised
3905Oncotype Dx Risk Level-DCIS.RSRSRCRC..NAACCR
3906Oncotype Dx Risk Level-Invasive.RSRSRCRC..NAACCR
3907Organomegaly.RSRSRSRSRS*RSNAACCRRevised
3908Percent Necrosis Post Neoadjuvant.RSRSRCRCRS*RSNAACCRRevised
3909Perineural Invasion.RSRSRSRS..NAACCR
3910Peripheral Blood Involvement.RSRSRSRSRS*RSNAACCRRevised
3911Peritoneal Cytology.RSRSRSRS..NAACCR
3913Pleural Effusion.RSRSRSRS..NAACCR
3914Progesterone Receptor Percent Positive or Range.RSRSRCRC..NAACCR
3915Progesterone Receptor SummaryRRSRSRSRSRS*RSNAACCRRevised
3916Progesterone Receptor Total Allred Score.RSRSRCRC..NAACCR
3917Primary Sclerosing Cholangitis .RSRSRCRC..NAACCR
3918Profound Immune Suppression.RSRSRSRS..NAACCR
3919EOD Prostate Pathologic Extension...RSRS..NAACCRRevised
3920PSA (Prostatic Specific Antigen) Lab ValueRRSRSRSRSRS*RSNAACCRRevised
3921Residual Tumor Volume Post Cytoreduction .RSRSRSRS..NAACCR
3922Response to Neoadjuvant Therapy.RSRSRCRC..NAACCR
3923S Category Clinical.RSRSRSRSRS*RSNAACCRRevised
3924S Category Pathological.RSRSRSRSRS*RSNAACCRRevised
3925Sarcomatoid Features.RSRSRSRS..NAACCR
3926Schema Discriminator 1RRSRSRSRSRS*RSNAACCRRevised
3927Schema Discriminator 2RRSRSRSRSRS*RSNAACCRRevised
3928Schema Discriminator 3.RSRSRSRSRS*RSNAACCRRevised
3929Separate Tumor Nodules.RSRSRSRS..NAACCR
3930Serum Albumin Pretreatment Level.RSRSRSRSRS*RSNAACCRRevised
3931Serum Beta-2 Microglobulin Pretreatment Level.RSRSRSRSRS*RSNAACCRRevised
3932LDH Lab ValueRRSRSRSRS..NAACCRRevised
3933Thrombocytopenia.RSRSRSRSRS*RSNAACCRRevised
3934Tumor Deposits.RSRSRSRS..NAACCR
3935Tumor Growth Pattern.RSRSRSRS..NAACCR
3936Ulceration.RSRSRSRSRS*RSNAACCRRevised
3937Visceral and Parietal Pleural Invasion.RSRSRSRS..NAACCR
3938ALK Rearrangement.RSR.NAACCRNew
3939EGFR Mutational Analysis.RSR.NAACCRNew
3940BRAF Mutational Analysis.RSR.NAACCRNew
3941NRAS Mutational Analysis.RSR.NAACCRNew
3942CA 19-9 PreTX Lab Value.RSR.NAACCRNew
3943NCDB--SARSCoV2--Test.R*R*.CoCNew
3944NCDB--SARSCoV2--Pos.R*R*.CoCNew
3945NCDB--SARSCoV2--Pos Date.R*R*.CoCNew
3946NCDB--COVID19--Tx Impact.R*R*.CoCNew
7010Path Reporting Fac ID 1.......HL7
7011Path Reporting Fac ID 2.......HL7
7012Path Reporting Fac ID 3.......HL7
7013Path Reporting Fac ID 4.......HL7
7014Path Reporting Fac ID 5.......HL7
7090Path Report Number 1.......HL7
7091Path Report Number 2.......HL7
7092Path Report Number 3.......HL7
7093Path Report Number 4.......HL7
7094Path Report Number 5.......HL7
7100Path Order Phys Lic No 1.......HL7
7101Path Order Phys Lic No 2.......HL7
7102Path Order Phys Lic No 3.......HL7
7103Path Order Phys Lic No 4.......HL7
7104Path Order Phys Lic No 5.......HL7
7190Path Ordering Fac No 1.......HL7
7191Path Ordering Fac No 2.......HL7
7192Path Ordering Fac No 3.......HL7
7193Path Ordering Fac No 4.......HL7
7194Path Ordering Fac No 5.......HL7
7320Path Date Spec Collect 1.......HL7
7321Path Date Spec Collect 2.......HL7
7322Path Date Spec Collect 3.......HL7
7323Path Date Spec Collect 4.......HL7
7324Path Date Spec Collect 5.......HL7
7480Path Report Type 1.......HL7
7481Path Report Type 2.......HL7
7482Path Report Type 3.......HL7
7483Path Report Type 4.......HL7
7484Path Report Type 5.......HL7